Flailing Merrimack brings out the ax for another big cutback, lopping 60% of a shrinking crew as it hunts options
Things at Merrimack Pharmaceuticals $MACK continue to go from bad to worse for the fast-dwindling band of survivors that now runs the show.
Just a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
